In a research report issued today, analyst Andrew Fein of H.C.
In a research report issued today, H.C.
In a research note issued today, William Blair analyst John Sonnier reiterated an Outperform rating on Threshold Pharmaceuticals (THLD), following the company’s second-quarter results, which were in line with the Street’s estimate. …
